From The Stage

BioAgilytix Team Q&A: Meet Chris Carlin

Posted by BioAgilytix / / BioAgilytix Insight, CRO Selection

Tell us a little about your background and how you came to join BioAgilytix. My first wet lab experience was gained during my undergrad studies at Bowdoin College in southern Maine. I majored in biology and completed an honors thesis through an exploratory study of an uncharacterized genetic locus in a pathogenic yeast. Thereafter, I moved to Boston and worked for three years at the Ragon Institute of MGH, MIT and Harvard, where I analyzed expression profiles of proteases in the blood cells of HIV+ patients. I then transitioned into…

BioAgilytix Team Q&A: Meet Reema Davis

Posted by BioAgilytix / / BioAgilytix Insight, CRO Selection

Tell us a little about your background and how you came to join BioAgilytix. I did my doctoral and postdoctoral training in Cell Biology. My fascination with blood and lymphatic vessels led me to research their genetic make-up and related diseases, in hopes to find potential drug targets. During my research I trained extensively in cell-based work including but not limited to gene expression studies, intracellular signaling, cellular staining, transduction, all of which helped me build a strong foundation of transferable skills. I interviewed at BioAgilytix through Hannah Powell’s referral…

BioAgilytix Team Q&A: Meet Nikhil Soni

Posted by BioAgilytix / / BioAgilytix Insight, CRO Selection

Tell us a little about your background and how you came to join BioAgilytix. Some of my friends at my previous job joined BAL and told me about how much they liked it here. What is your current role, and how has it evolved since joining the team? Scientist III/BPM. Since joining the team I’ve had 4 analysts and scientists added under me. Along with that I’ve been given the responsibility of managing all aspects of multiple large studies. This has given me a lot of experience in both project…

COVID-19 Employee Testing: Where to Begin?

Dr. Chad Briscoe
Posted by Dr. Chad Briscoe / / BioAgilytix Insight, COVID-19

Every employer realizes that protecting employees’ health is paramount right now, but with so many uncertainties they need confidence that their testing strategy is optimized for success. We take a close look at parameters to consider in building an effective, sustainable COVID-19 employee testing plan.

CLIA, COLA & CAP: What’s the Difference?

Natalie Smith
Posted by Natalie Smith / / BioAgilytix Insight, Regulatory Considerations

BioAgilytix’s CLIA Laboratory Director, Natalie Smith, outlines the differences between CLIA, CAP & COLA regulations & accreditations, and what they mean for laboratory testing quality.